-
4
-
-
0023922084
-
Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer-report of a Canadian multicenter randomized trial
-
(1988)
J Clin Oncol
, vol.6
, pp. 633-641
-
-
Rapp, E.1
Pater, J.L.2
Willan, A.3
-
5
-
-
0024562637
-
Supportive care vs. supportive care and combination chemotherapy in metastatic non-small-cell lung cancer. Does chemotherapy make a difference?
-
(1989)
Cancer
, vol.63
, pp. 1271-1278
-
-
Ganz, P.A.1
Figlin, R.A.2
Haskell, C.M.3
-
6
-
-
0027159808
-
Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care vs. supportive care alone for treatment of metastatic non-small-cell lung cancer
-
(1993)
J Natl Cancer Inst
, vol.85
, pp. 794-800
-
-
Cartei, G.1
Cartei, F.2
Cantone, A.3
-
8
-
-
0034160108
-
A multicenter, randomized, phase III study of docetaxel plus best supportive care vs. best supportive care in chemotherapy-naïve patients with metastatic or non-resectable localized non-small-cell lung cancer (NSCLC)
-
(2000)
Lung Cancer
, vol.37
, Issue.3
, pp. 145-157
-
-
Roszkowski, K.1
Pluzanska, A.2
Krzakowski, M.3
-
10
-
-
0006453669
-
Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer
-
The Elderly Lung Cancer Vinorelbine Italian Study Group
-
(1999)
J Natl Cancer Inst
, vol.91
, pp. 66-72
-
-
-
11
-
-
0001913280
-
Phase III study of gemcitabine (Gemzar®) vs. best supportive care (BSC) in advanced non-small-cell lung cancer (NSCLC)
-
(Abstr 24 and oral presentation in Dublin, Ireland, 1997).
-
(1997)
Lung Cancer
, vol.18
, Issue.1
, pp. 9
-
-
Anderson, H.1
Cottier, B.2
Nicolson, M.3
-
12
-
-
0033950286
-
Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin vs. etoposide with cisplatin: Results of an Eastern Cooperative Group trial
-
(2000)
J Clin Oncol
, vol.18
, pp. 623-631
-
-
Bonomi, P.1
Kim, K.M.2
Fairclough, D.3
-
13
-
-
0028154069
-
Randomized study of vinorelbine and cisplatin vs. vindesine and cisplatin vs. vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients
-
(1994)
J Clin Oncol
, vol.12
, pp. 360-367
-
-
Le Chevalier, T.1
Brisgand, D.2
Douillard, J.Y.3
-
15
-
-
0000510626
-
A randomized phase III trial of paclitaxel plus carboplatin (PC) vs. vinorelbine plus cisplatin (VC) in untreated advanced non-small-cell lung cancer (NSCLC): A Southwest Oncology Group (SWOG) trial
-
(Abstr 1777)
-
(1999)
Proc Am Soc Clin Oncol
, vol.18 a
-
-
Kelly, K.1
Crowley, J.2
Bunn, P.3
-
17
-
-
0030878725
-
Single-agent docetaxel in previously untreated non-small-cell lung cancer
-
(1997)
Oncology
, vol.11
, Issue.SUPPL. 7
, pp. 17-21
-
-
Rigas, J.R.1
-
24
-
-
0034069620
-
Prospective randomized trial of docetaxel vs. best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy
-
(2000)
J Clin Oncol
, vol.18
, Issue.10
, pp. 2095-2103
-
-
Shepherd, F.1
Ramlau, R.2
Mattson, K.3
-
25
-
-
0034095853
-
Randomized phase III trial of docetaxel vs. vinorelbine or ifosfamide in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy
-
(2000)
J Clin Oncol
, vol.18
, Issue.12
, pp. 2354-2362
-
-
Fossella, F.V.1
DeVore, R.2
Kerr, R.3
-
31
-
-
0028937815
-
Epidermal growth factor (EGFR) expression in non small-cell lung carcinomas correlates with metastic involvement of the hilar and mediastinal lymph nodes squamous subtypes
-
(1995)
Eur J Cancer
, vol.31 A
, pp. 178-183
-
-
Fontanini, G.1
Vignati, S.2
Bigini, D.3
-
33
-
-
0000240853
-
Continuous administration of ZD1839 (Iressa), a novel oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in patients with five selected tumor types: Evidence of activity and good tolerability
-
(Abstr 686)
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
-
-
Baselga, J.1
Herbst, R.2
Lorusso, P.3
-
34
-
-
0000397265
-
A randomized phase II trial comparing rhuMab VEGF (recombinant humanized monoclonal antibody to vascular endothelial cell growth factor) plus carboplatin/paclitaxel alone in patients with stage IIIB/IV NSCLC
-
(Abstr 1896)
-
(2000)
Proc Am Soc Clin Oncol
, vol.19
, pp. 485
-
-
DeVore, R.F.1
Fehrenbacher, L.2
Herbst, R.S.3
-
35
-
-
0028843552
-
Non-Small-Cell Lung Cancer Collaborative Group: Chemotherapy in non-small-cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials
-
(1995)
BMJ
, vol.311
, pp. 899-909
-
-
|